Emerging Natural Therapies for the Treatment of Inflammatory Bowel Disease

被引:1
|
作者
Joshi, Monika [1 ,2 ]
Pandey, Manju [1 ]
Shankar, Ravi [3 ]
Ved, Akash [4 ]
机构
[1] Sri Ramswaroop Mem Univ, Inst Pharm, Barabanki 225003, UP, India
[2] Maharshi Univ Informat Technol, Dept Pharm, Noida, UP, India
[3] GLA Univ, Inst Pharmaceut Res, Mathura 281406, UP, India
[4] Dr APJ Abdul Kalam Tech Univ, Fac Pharm, Lucknow 226031, UP, India
关键词
Chron's disease; Herbal therapy; inflammatory bowel disease; Medicinal plants; Ulcerative colitis; WORMWOOD ARTEMISIA-ABSINTHIUM; ACTIVE ULCERATIVE-COLITIS; RANDOMIZED CLINICAL-TRIAL; DOUBLE-BLIND; BOSWELLIA-SERRATA; CROHNS-DISEASE; EXTRACT HMPL-004; MICROBIOTA; REMISSION; CURCUMIN;
D O I
10.2174/0113892010293150240415143650
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The term "inflammatory bowel disease," which includes Crohn's disease (CD) and ulcerative colitis (UC), refers to a chronic inflammatory condition of the digestive system. There are many different treatment options, such as corticosteroids, biologics, 5-aminosalicylate, and immune-suppressants, but none of them can maintain the disease remission for a longer period, which is the ultimate goal of treatment. Furthermore, they have numerous serious side effects like nephrotoxicity, infertility, congestive heart failure, myopathy, etc. So, in order to treat these conditions, researchers are concentrating more on natural medicine that is less expensive and has fewer side effects. The current analysis includes a list of plants showing promising activity against IBD. These include Cannabis sativa, Aloe vera, Boswellia serrata, Withania somnifera, Curcuma longa, Triticum aestivum, and many others. These plants need to be further investigated in terms of preclinical and clinical studies to obtain the safety and efficacy data necessary for their commercialisation. Global regulatory norms will facilitate simple commercialisation. Also, more investigation is required to pinpoint the precise mechanism of action to confirm clinical success.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Emerging Therapies for Inflammatory Bowel Disease
    Roni Weisshof
    Katia El Jurdi
    Nada Zmeter
    David T. Rubin
    Advances in Therapy, 2018, 35 : 1746 - 1762
  • [2] Emerging Therapies for Inflammatory Bowel Disease
    Weisshof, Roni
    El Jurdi, Katia
    Zmeter, Nada
    Rubin, David T.
    ADVANCES IN THERAPY, 2018, 35 (11) : 1746 - 1762
  • [3] Inflammatory Bowel Disease: Emerging Therapies and Future Treatment Strategies
    Bretto, Elisabetta
    Ribaldone, Davide Giuseppe
    Caviglia, Gian Paolo
    Saracco, Giorgio Maria
    Bugianesi, Elisabetta
    Frara, Simone
    BIOMEDICINES, 2023, 11 (08)
  • [4] Phosphodiesterase inhibitors and inflammatory bowel disease: emerging therapies in inflammatory bowel disease
    Keshavarzian, Ali
    Mutlu, Ece
    Guzman, Juan P.
    Forsyth, Christopher
    Banan, Ali
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (09) : 1489 - 1506
  • [5] Novel and Emerging Therapies for Inflammatory Bowel Disease
    Al-Bawardy, Badr
    Shivashankar, Raina
    Proctor, Deborah D.
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [6] Review: emerging drug therapies in inflammatory bowel disease
    Grossberg, Laurie B.
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (07) : 789 - 804
  • [7] New therapies for the treatment of inflammatory bowel disease
    Sands, Bruce E.
    SURGICAL CLINICS OF NORTH AMERICA, 2006, 86 (04) : 1045 - +
  • [8] Emerging Therapies for Inflammatory Bowel Diseases
    Khanna, Reena
    Feagan, Brian G.
    DIGESTIVE DISEASES, 2016, 34 : 67 - 73
  • [9] Emerging drugs for the treatment of inflammatory bowel disease
    Wong, Uni
    Cross, Raymond K.
    EXPERT OPINION ON EMERGING DRUGS, 2022, 27 (04) : 369 - 377
  • [10] Emerging opportunities for the treatment of inflammatory bowel disease
    Gale, JD
    McClure, KF
    Pullen, N
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 38, 2003, 38 : 141 - 152